erlotinib hydrochloride has been researched along with fr 180204 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (fr 180204) | Trials (fr 180204) | Recent Studies (post-2010) (fr 180204) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 39 | 0 | 33 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | fr 180204 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macigova, P; Mudry, P; Neradil, J; Noskova, H; Polaskova, K; Slaby, O; Sramek, M; Sterba, J; Veselska, R | 1 |
1 other study(ies) available for erlotinib hydrochloride and fr 180204
| Article | Year |
|---|---|
Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a
Topics: Butadienes; Cell Line, Tumor; Cell Proliferation; Child; Erlotinib Hydrochloride; Female; Humans; Infant; Male; Mutation; Myofibromatosis; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Receptor, Platelet-Derived Growth Factor beta; Sunitinib | 2018 |